A detailed history of Berkeley, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Berkeley, Inc holds 28,193 shares of MRK stock, worth $2.53 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares
28,193
Previous 56,500 50.1%
Holding current value
$2.53 Million
Previous $6.42 Billion 56.29%
% of portfolio
1.45%
Previous 1.87%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 28, 2025

SELL
$96.31 - $114.76 $2.73 Million - $3.25 Million
-28,307 Reduced 50.1%
28,193 $2.8 Billion
Q4 2024

Mar 05, 2025

SELL
$96.31 - $114.76 $5,489 - $6,541
-57 Reduced 0.2%
28,193 $2.8 Billion
Q3 2024

Mar 28, 2025

BUY
$111.15 - $128.97 $3.15 Million - $3.65 Million
28,307 Added 100.4%
56,500 $6.42 Billion
Q3 2024

Mar 05, 2025

BUY
$111.15 - $128.97 $6,446 - $7,480
58 Added 0.21%
28,250 $3.21 Billion
Q2 2024

Mar 28, 2025

SELL
$123.8 - $132.96 $84,184 - $90,412
-680 Reduced 2.36%
28,192 $3.49 Billion
Q2 2024

Mar 05, 2025

SELL
$123.8 - $132.96 $84,184 - $90,412
-680 Reduced 2.36%
28,192 $3.49 Billion
Q1 2024

Mar 28, 2025

BUY
$113.24 - $131.95 $22,761 - $26,521
201 Added 0.7%
28,872 $3.81 Billion
Q1 2024

Mar 05, 2025

BUY
$113.24 - $131.95 $22,761 - $26,521
201 Added 0.7%
28,872 $3.81 Billion
Q4 2023

Mar 28, 2025

SELL
$100.18 - $109.02 $34,762 - $37,829
-347 Reduced 1.2%
28,671 $3.13 Billion
Q4 2023

Mar 04, 2025

SELL
$100.18 - $109.02 $34,762 - $37,829
-347 Reduced 1.2%
28,671 $3.13 Billion
Q3 2023

Mar 28, 2025

SELL
$102.95 - $114.33 $7,103 - $7,888
-69 Reduced 0.24%
29,018 $2.99 Billion
Q3 2023

Mar 04, 2025

SELL
$102.95 - $114.33 $7,103 - $7,888
-69 Reduced 0.24%
29,018 $2.99 Billion
Q2 2023

Mar 28, 2025

BUY
$108.61 - $118.38 $8,145 - $8,878
75 Added 0.26%
29,087 $3.36 Billion
Q2 2023

Mar 04, 2025

BUY
$108.61 - $118.38 $8,145 - $8,878
75 Added 0.26%
29,087 $3.36 Billion
Q1 2023

Mar 28, 2025

SELL
$102.94 - $114.86 $69,072 - $77,071
-671 Reduced 2.26%
29,012 $3.09 Billion
Q1 2023

Mar 04, 2025

SELL
$102.94 - $114.86 $69,072 - $77,071
-671 Reduced 2.26%
29,012 $3.09 Billion
Q4 2022

Mar 28, 2025

BUY
$87.44 - $112.11 $130,285 - $167,043
1,490 Added 5.28%
29,683 $3.29 Billion
Q4 2022

Mar 04, 2025

SELL
$87.44 - $112.11 $151,358 - $194,062
-1,731 Reduced 5.51%
29,683 $3.29 Billion
Q3 2022

Mar 28, 2025

BUY
$84.53 - $94.96 $74,470 - $83,659
881 Added 2.89%
31,414 $2.71 Billion
Q3 2022

Mar 04, 2025

BUY
$84.53 - $94.96 $74,470 - $83,659
881 Added 2.89%
31,414 $2.71 Billion
Q2 2022

Mar 28, 2025

BUY
$83.49 - $94.64 $105,948 - $120,098
1,269 Added 4.34%
30,533 $2.78 Billion
Q2 2022

Mar 04, 2025

BUY
$83.49 - $94.64 $105,948 - $120,098
1,269 Added 4.34%
30,533 $2.78 Billion
Q1 2022

Mar 28, 2025

BUY
$73.51 - $82.4 $330,427 - $370,388
4,495 Added 18.15%
29,264 $2.4 Billion
Q1 2022

Mar 04, 2025

BUY
$73.51 - $82.4 $330,427 - $370,388
4,495 Added 18.15%
29,264 $2.4 Billion
Q4 2021

Mar 28, 2025

BUY
$72.28 - $90.54 $1.07 Million - $1.34 Million
14,852 Added 149.76%
24,769 $1.9 Billion
Q4 2021

Mar 04, 2025

BUY
$72.28 - $90.54 $1.07 Million - $1.34 Million
14,852 Added 149.76%
24,769 $1.9 Billion
Q3 2021

Mar 28, 2025

BUY
$71.68 - $78.83 $31,754 - $34,921
443 Added 4.68%
9,917 $745 Million
Q3 2021

Mar 04, 2025

BUY
$71.68 - $78.83 $31,754 - $34,921
443 Added 4.68%
9,917 $745 Million
Q2 2021

Mar 28, 2025

BUY
$70.31 - $77.77 $4,429 - $4,899
63 Added 0.67%
9,474 $737 Million
Q2 2021

Mar 04, 2025

BUY
$70.31 - $77.77 $4,429 - $4,899
63 Added 0.67%
9,474 $737 Million
Q1 2021

Mar 28, 2025

SELL
$68.86 - $81.11 $1.29 Million - $1.52 Million
-18,782 Reduced 66.62%
9,411 $726 Million
Q1 2021

Mar 04, 2025

BUY
$68.86 - $81.11 $14,873 - $17,519
216 Added 2.35%
9,411 $726 Million
Q4 2020

Mar 28, 2025

SELL
$71.77 - $79.65 $1.36 Million - $1.51 Million
-18,998 Reduced 67.39%
9,195 $752 Million
Q4 2020

Feb 28, 2025

BUY
$71.77 - $79.65 $659,925 - $732,381
9,195 New
9,195 $752 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $227B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Berkeley, Inc Portfolio

Follow Berkeley, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley, Inc with notifications on news.